CONCILIUS AG

Tweet this page
<
2023
2024
>
Registration as it was on 22 Oct 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

435,000€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

5 Fte (6)

Lobbyists with EP accreditation

6

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    CONCILIUS AG

    EU Transparency Register

    695550548409-69 First registered on 16 Dec 2022

    Goals / Remit

    CONCILIUS advises companies, associations and other social actors at the interfaces with politics and administration in Germany and with the institutions of the European Union. With offices not only in Berlin and Brussels, but also in Munich, Stuttgart, Dusseldorf and Hamburg, we are able to address the special requirements of the federal political system in the best possible way. In addition to our services at EU, federal and state level, our clients value our expertise in supporting projects at the municipal level. Our consultants have excellent references and decades of experience in successfully dealing with regulatory issues in almost every industry sector. We emphasise a comprehensible, analysis-based and content- and target-oriented approach.
    CONCILIUS was founded in 2003 and is still managed by its owners.

    Main EU files targeted

    European Standardization Strategy; New Legislative Framework; Ecodesign for Sustainable Products – Product priorities; European Critical Raw Materials Act; Cyber Resilience Act; Artificial Intelligence Act; Standard Essential Patents; Construction Products Regulation; European Strategy for Data; EU Hydrogen Strategy; Digital Product Passport; Smart Farming; Cybersecurity; Malamud Case; Toy Safety Regulation; Right to Repair; Circular Economy Action Plan; European Green Deal; Batteries and waste batteries; Directive amending the Renewable Energy, Energy Performance of Buildings and Energy Efficiency Directives; EU space strategy for security and defence; Empowering consumers for the green transition; Establishing a European Bank for Hydrogen; Establishing the Single Market Emergency Instrument; European Chips Act; European Digital Identity; European Health Data Space; Industrial Emissions Directive; Cyber Solidarity Act; Proposal for a revision of EU legislation on Packaging and Packaging Waste; Clean Tech Act; Renewable Energy Directive; Alternative Fuel Infrastructure Regulation; Corporate Due Diligence Directive; Data Act; Product Liability Directive and Artificial Product Liability Directive; Electricity Market Design Reform; Renewable Energy Directive II: Access to vehicle data, functions and resources; Road Safety Package (autonomous diving maybe included); Euro 7; Industrial Green Deal; Net Zero Industry Act; Energy Taxation Directive; Payment Service Directive; Green Transport Package; EU Emissions Trading System; Carbon Border Adjustment Mechanism; Regulation on the approval and market surveillance of motor vehicles and their trailers, and of systems, components and separate technical units intended for such vehicles TEN-T; Digital Battery Pass; Autonomous Driving; Electric Vehicles; General Product Safety Regulation; Market Surveillance Regulation; Online fairness/dark patterns/withdrawals; Digital Services Act; Consumer Protection Cooperation Regulation; Alternative and Online Dispute Resolution Directive and Regulation; Vertical Block Exemption Regulation; Regulation on classification, labelling, and packaging of chemicals; Registration, Evaluation, Authorization and Restriction of Chemicals; Detergents Regulation; Cosmetic Products Regulation; Intellectual Property Enforcement Directive; Empowering Consumers for the Green Transition Directive; Green Claims Directive; Corporate Sustainability Due Diligence Directive; Forced Labour Regulation; Corporate Sustainability Reporting Directive; EU Taxonomy; CountEmissionsEU initiative; CO2 emission standards for trucks regulation; Sustainable Consumption of Goods initiative; EcoDesign Directive; Regulation on the Certification of Carbon Removals; VAT in the digital age Package; EU Customs Reform initiative; Anti-Money Laundering Regulation; Instant Payments Regulation; Digital Euro; eIDAS; Regulation on Horizontal Cybersecurity Requirements for Products with Digital Elements; Directive on Platform Work; EU Pharma Regulation; Artificial Intelligence Liability Directive; Secure Satellite Connectivity (IRIS2) implementation; Space Traffic Management Strategy and Space Law; Fair Share/ Network Tax policy; Regulation on Child Sexual Abuse Material (CSAM); Gigabit Infrastructure Act; Directive on improving working conditions in platform work; Revision of the General Pharmaceutical Legislation; Revision of Orphan Medicinal Products Legislation; EMA Fees regulation; Cross border Healthcare directive; Health Emergency Preparedness and Response Authority (HERA); Patent Package – SPC/uPSC for medicinal products, compulsory licensing; ‘Healthier Together’ Non Communicable Diseases plan; Industrial Strategy, Important Projects of Common European Interest (IPCEI) on health; Pharmaceutical Strategy; International Trade; International Health Regulations; WHO Pandemic Treaty – TRIPS waiver; EU-US relations;Non-communicable diseases, especially Diabetes, Alzheimer’s and Obesity.

    Address

    Head Office
    Hermann-Sack-Strasse 3
    Munich 80331
    GERMANY
    EU Office
    CONCILIUS Europe SRLAvenue de Cortenbergh 52
    Brussels 1000
    BELGIUM

    Website

  • People

    Total lobbyists declared

    6

    Employment timeLobbyists
    100%4
    75%1
    25%1

    Lobbyists (Full time equivalent)

    5

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    6 accreditations were / are live (in bold) for the selected state of 26 Dec 2024

    Name Start date End Date
    Markus Russ 01 Nov 2024 30 Oct 2025
    Arianna COLAIUTA 01 Nov 2024 30 Oct 2025
    Lennart Dröge 01 Nov 2024 30 Oct 2025
    Timothy MORRIS 01 Nov 2024 30 Oct 2025
    Marta DAKIC 01 Nov 2024 30 Oct 2025
    Sophie Löw 01 Nov 2024 30 Oct 2025
    Sophie LOEW 22 Feb 2024 04 Oct 2024
    Timothy MORRIS 22 Feb 2024 04 Oct 2024
    Marta DAKIC 22 Feb 2024 04 Oct 2024
    Arianna COLAIUTA 22 Feb 2024 04 Oct 2024
    Lennart DROEGE 22 Feb 2024 04 Oct 2024
    Sophie LOEW 30 Mar 2023 22 Feb 2024
    Lennart DROEGE 23 Feb 2023 22 Feb 2024
    Marta DAKIC 21 Feb 2023 21 Feb 2024
    Arianna COLAIUTA 21 Feb 2023 21 Feb 2024
    Ms Mirjam FRAKULLA 21 Feb 2023 21 Feb 2024

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Professional consultancies

  • Networking

    Affiliation

    American Chamber of Commerce in Germany e.V.
    de'ge'pol - Deutsche Gesellschaft für Politikberatung e.V.
    Deutsche Gesellschaft für Auswärtige Politik e. V.
    DEUTSCHE GESELLSCHAFT FÜR WEHRTECHNIK e. V. (DWT)
    Förderkreis Deutsches Heer e.V.
    Forum Luft- und Raumfahrt e.V.
    Wirtschaftsforum der SPD e.V.
    Wirtschaftsbeirat Bayern - Wirtschaftsbeirat der Union e.V.
    Wirtschaftsrat der CDU e. V.

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Advances interests of their clients

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    435,000€

    Major contributions in closed year

    None declared

    Clients for closed financial year

    Clients list
    NameProposalAmount
    alexion pharmaceuticals Revision of the General Pharmaceutical Legislation; Revision of Orphan Medicinal Products Legislation; EMA Fees regulation; Cross border Healthcare directive; European Health Data Space and its interplay with other digital legislation such as GDPR, Data Act; Clinical trials regulation; EU HTA regulation; Intellectual Property Rights and Incentives; Pharmaceutical strategy; EU Beating Cancer Plan; Regulation on the safety and quality of substances of human origin (SoHO); Health Emergency Preparedness and Response Authority (HERA) 100,000€ - 199,999€
    Eli Lilly and Company Revision of the General Pharmaceutical Legislation; Revision of the Orphan Medicinal Products Legislation; Patent Package – SPC/uPSC for medicinal products, compulsory licensing; Beating Cancer Plan; European Health Data Space, and its interplay with other digital legislation such as GDPR, Data Act; EMA Fees regulation; ‘Healthier Together’ Non-Communicable Diseases plan; Intellectual Property Rights and Incentives; Industrial Strategy, Important Projects of Common European Interest (IPCEI) on health; Pharmaceutical Strategy; International Trade; International Health Regulations; Clinical trials regulation; WHO Pandemic Treaty – TRIPS waiver; EU-US relations; Non-communicable diseases, especially Diabetes, Alzheimer’s and Obesity 50,000€ - 99,999€
    din deutsches institut für normung e. v. European Standardization Strategy; New Legislative Framework; Ecodesign for Sustainable Products – Product priorities; European Critical Raw Materials Act; Cyber Resilience Act; Artificial Intelligence Act; Standard Essential Patents; Construction Products Regulation; European Strategy for Data; EU Hydrogen Strategy; Digital Product Passport; Smart Farming; Cybersecurity; Malamud Case; Construction Product Regulation; Toy Safety Regulation; Right to Repair; Circular Economy Action Plan; European Green Deal; Batteres and waste batteries; Directive amending the Renewable Energy, Energy Performgance of Buildings and Energy Efficiency Directives; EU space strategy for security and defence; Ecodesign for Sustainable Products Regulation; Empowering consumers for the green transition; Establishing a European Bank for Hydrogen; Establishing the Single Market Emergency Instrument; European Chips Act; European Digital Identity; European Health Data Space; Industrial Emissions Directive (...) 50,000€ - 99,999€
    Amazon Europe Core SARL General Product Safety Regulation; Product Liability Directive; Market Surveillance Regulation; Online fairness/dark patterns/withdrawals; Digital Services Act; Consumer Protection Cooperation Regulation; Alternative and Online Dispute Resolution Directive and Regulation; Vertical Block Exemption Regulation; Toy Safety Directive; Regulation on classification, labelling, and packaging of chemicals; Registration, Evaluation, Authorization and Restriction of Chemicals; Detergents Regulation; Cosmetic Products Regulation; Intellectual Property Enforcement Directive; Regulation on Standards Essential Patents; Empowering Consumers for the Green Transition Directive; Green Claims Directive; Corporate Sustainability Due Diligence Directive; Forced Labour Regulation; Corporate Sustainability Reporting Directive; EU Taxonomy; Alternative Fuels Infrastructure Regulation; CountEmissionsEU initiative; CO2 emission standards for trucks regulation; Packaging and Packaging Waste Regulation (...) 50,000€ - 99,999€
    dahag rechtsservices ag Directive on improving working conditions in platform work 50,000€ - 99,999€
    BASF SE Cosmetic Products Regulation (CPR) 50,000€ - 99,999€
    daiichi sankyo europe gmbh Revision of the General Pharmaceutical Legislation; Revision of Orphan Medicinal Products Legislation; EMA Fees regulation; Cross border Healthcare directive; European Health Data Space and its interplay with other digital legislation such as GDPR, Data Act; Clinical trials regulation; EU HTA regulation; Intellectual Property Rights and Incentives; Pharmaceutical strategy; EU Beating Cancer Plan; Regulation on the safety and quality of substances of human origin (SoHO); Health Emergency Preparedness and Response Authority (HERA); Urban Wastewater Treatment Directive (UWWTD) 25,000€ - 49,999€
    Bolt Platform Workers Directive, VAT in the Digital Age, Sustainable and Smart Mobility Strategy, Greening corporate fleets 25,000€ - 49,999€
    nio gmbh Alternative Fuel Infrastructure Regulation; Corporate Due Diligence Directive; Artificial Intelligence Act; Data Act; Critical Raw Materials Act; Cyber Resilience Act; Regulation on Batteries and waste Batteries; Product Liability Directive and Artificial Product Liability Directive; Electricity Market Design Reform; Renewable Energy Directive II: Access to vehicle data, functions and resources; Road Safety Package (autonomous diving maybe included); Euro 7; Industrial Green Deal; Net Zero Industry Act; Energy Taxation Directive; Payment Service Directive; Green Transport Package; EU Emissions Trading System; Carbon Border Adjustment Mechanism; Regulation on the approval and market surveillance of motor vehicles and their trailers, and of systems, components and separate technical units intended for such vehicles TEN-T; Digital Battery Pass; Autonomous Driving; Electric Vehicles 25,000€ - 49,999€
    European Confederation of Pharmaceutical Entrepreneurs Revision of the General Pharmaceutical Legislation; Revision of Orphan Medicinal Products Legislation; EMA Fees regulation; Cross border Healthcare directive; European Health Data Space and its interplay with other digital legislation such as GDPR, Data Act; Clinical trials regulation; EU HTA regulation; Intellectual Property Rights and Incentives; Pharmaceutical strategy; EU Beating Cancer Plan; Regulation on the safety and quality of substances of human origin (SoHO); Health Emergency Preparedness and Response Authority (HERA) 10,000€ - 24,999€

    Clients for current financial year

    Clients list
    Name
    Eli Lilly and Company
    Amazon Europe Core SARL
    alexion pharmaceuticals
    din deutsches institut für normung e. v.
    European Confederation of Pharmaceutical Entrepreneurs
    Bolt

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    None declared

    Groups (European Parliament)

    N/A

    Communication activities

    Conference, virtual events, virtual and non-virtual meetings, report on annual activities

    Other activities

    None declared

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

    • Date 22 Nov 2022 Location Webex
      Subject Meeting with OD Expert Group on rare diseases, including EURORDIS, EUCOPE, Chiesi, EJP RD and Copenhagen Economics
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Karolina Herbout-Borczak (Cabinet member)
Download this datacard